Get the Stockscreener App
0.00
100.00%
-90.00
After Hours:
88.97
88.97
+
Merus N V stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
See More
Previous Close:
$90.00
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$6.83B
Revenue:
$35.93M
Net Income/Loss:
$-244.56M
P/E Ratio:
0.00
EPS:
-3.95
Net Cash Flow:
$-157.31M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$96.86
52-Week Range:
$0.00
$97.14
Merus N V Stock (MRUS) Company Profile
Name
Merus N V
Sector
Industry
Phone
31 030 253 8800
Address
YALELAAN 62, 3584 CM UTRECHT
Compare MRUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
0.00 | 6.83B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Initiated | Barclays | Overweight |
| Aug-25-25 | Initiated | Alliance Global Partners | Buy |
| Feb-13-25 | Initiated | Piper Sandler | Overweight |
| Feb-07-25 | Initiated | Wells Fargo | Overweight |
| Nov-21-24 | Initiated | Goldman | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Mar-28-24 | Initiated | Truist | Buy |
| Mar-04-24 | Reiterated | Needham | Buy |
| Nov-02-23 | Initiated | Canaccord Genuity | Buy |
| Aug-21-23 | Initiated | TD Cowen | Outperform |
| Aug-02-22 | Initiated | Stifel | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Feb-10-22 | Initiated | Needham | Buy |
| Nov-17-21 | Resumed | Guggenheim | Buy |
| Jun-07-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-21 | Initiated | William Blair | Outperform |
| Mar-16-21 | Initiated | SVB Leerink | Outperform |
| Jun-26-20 | Initiated | H.C. Wainwright | Buy |
| May-27-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-20-19 | Resumed | Guggenheim | Buy |
| Jun-28-19 | Initiated | ROTH Capital | Buy |
| Apr-12-19 | Resumed | Guggenheim | Buy |
| Apr-03-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Jan-02-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Mar-21-17 | Downgrade | Citigroup | Buy → Neutral |
| Dec-22-16 | Upgrade | Citigroup | Neutral → Buy |
| Nov-07-16 | Downgrade | Citigroup | Buy → Neutral |
| Jun-13-16 | Initiated | Citigroup | Buy |
| Jun-13-16 | Initiated | Guggenheim | Buy |
| Jun-13-16 | Initiated | Wedbush | Outperform |
View All
Merus N V Stock (MRUS) Latest News
Genmab Announces $2.5 Billion Note Offering for Merus Acquisition - MSN
What analysts say about Merus NV stockTrading Volume Surges & Outstanding Investment Returns - earlytimes.in
Retail Trends: How Merus NV 2GH stock moves in volatile trading sessionsProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Why retail investors favor Merus N.V. stockEconomic Indicators Overview & Low Risk Capital Growth Plans - bollywoodhelpline.com
Moody Aldrich Partners LLC Reduces Position in Merus N.V. $MRUS - MarketBeat
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus - ts2.tech
A/S Genmab Purchases 1,052,806 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout - ts2.tech
Merus Completes Genmab Acquisition and Delists From Nasdaq - TipRanks
Genmab completes acquisition of Merus and delists shares from Nasdaq - Investing.com
Merus Announced Transfer or Voluntary Withdrawal of Listing - TradingView — Track All Markets
Simplify Asset Management Inc. Takes $3.14 Million Position in Merus N.V. $MRUS - MarketBeat
Merus (NASDAQ:MRUS) Major Shareholder A/S Genmab Acquires 96,082 Shares - MarketBeat
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Acquires 142,610 Shares of Stock - MarketBeat
A/S Genmab Purchases 561,042 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Purchases 15,710 Shares of Stock - MarketBeat
Merus (NASDAQ:MRUS) Stock Price Down 7%Here's Why - MarketBeat
Fed Watch: Why Merus NV 2GH stock stays undervaluedLong Setup & Weekly Breakout Watchlists - moha.gov.vn
Merus N.V. (NASDAQ:MRUS) Sees Large Decrease in Short Interest - MarketBeat
Stock Traders Buy High Volume of Call Options on Merus (NASDAQ:MRUS) - MarketBeat
Harbor Capital Advisors Inc. Trims Stock Holdings in Merus N.V. $MRUS - MarketBeat
Revenue per share of Merus N.V. – FWB:2GH - TradingView — Track All Markets
GENMAB AS Insider Trades - Nasdaq
A/S Genmab Acquires 66,264 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
Merus N.V. $MRUS Stock Position Decreased by Voya Investment Management LLC - MarketBeat
A/S Genmab Acquires 212,177 Shares of Merus (NASDAQ:MRUS) Stock - MarketBeat
How Merus N.v. (MRUS) Affects Rotational Strategy Timing - Stock Traders Daily
MRUS SEC FilingsMerus 10-K, 10-Q, 8-K Forms - Stock Titan
Will Merus N.V. stock maintain dividend yieldJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
Is Merus N.V. (2GH) stock positioned for digital growth eraMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Will Merus N.V. stock maintain momentum in 2025Weekly Profit Summary & Stock Portfolio Risk Control - Улправда
How Merus N.V. (2GH) stock stacks up against competitorsQuarterly Earnings Report & Free Community Consensus Stock Picks - Улправда
How Merus N.V. (2GH) stock trades in high volatilityPrice Action & Advanced Technical Analysis Signals - DonanımHaber
How cyclical is Merus N.V. (2GH) stock compared to rivalsJuly 2025 Update & Advanced Swing Trade Entry Alerts - Улправда
Insider Buying: Merus (NASDAQ:MRUS) Major Shareholder Buys 150,795 Shares of Stock - MarketBeat
Owner Genmab A/S Buys 271,547 ($26.3M) Of Merus NV [MRUS] - TradingView — Track All Markets
Genmab (GMAB) reports 94.2% ownership of Merus at $97 per share - Stock Titan
Sanders Morris Harris LLC Buys Shares of 24,870 Merus N.V. $MRUS - MarketBeat
Merus N.V.(NasdaqGM: MRUS) dropped from S&P Global BMI Index - marketscreener.com
Merus (NASDAQ:MRUS) Sets New 12-Month HighShould You Buy? - MarketBeat
Merus NV stock hits all-time high at 96.95 USD By Investing.com - Investing.com South Africa
Merus NV stock hits all-time high at 96.95 USD - Investing.com
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B - Benzinga
Revenue per share of Merus N.V. – LSX:A2AKFX - TradingView — Track All Markets
Merus acquired by Genmab, leadership changes announced - MSN
Holocene Advisors LP Boosts Position in Merus N.V. $MRUS - MarketBeat
Boothbay Fund Management LLC Grows Holdings in Merus N.V. $MRUS - MarketBeat
Merus N.V. (NASDAQ:MRUS) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Genmab completes $6.9 billion acquisition of Merus N.V., triggers leadership changes - Investing.com Nigeria
[Form 4] Merus N.V. Insider Trading Activity - Stock Titan
Merus Acquired by Genmab, Leadership Changes Announced - TipRanks
Merus N V Stock (MRUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):